[Age-related cytokine regulation in children with malaria]

Insights

Children with malaria show age-related immune changes. Infants have suppressed Th-1 responses, while older children develop a more favorable Th-1 immunity, aiding malaria prognosis.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Context:

  • Tertian or tropical malaria infection in children presents complex immunological challenges.
  • Understanding age-related immune responses is crucial for managing pediatric malaria.

Purpose:

  • To investigate age-dependent alterations in cytokine profiles during childhood malaria.
  • To correlate immunological changes with disease severity and prognosis.

Summary:

  • Infants with malaria exhibit dysregulated immunity, characterized by elevated pro-inflammatory cytokines and reduced Interferon-gamma (IFN-gamma), indicating inhibited T-helper 1 (Th-1) responses.
  • As children age, a shift towards a Th-1 immune response is observed, correlating with a more favorable disease course.
  • These cytokine dysregulations are linked to the infectious process dynamics and pathological severity.

Impact:

  • Provides insights into the developing immune system's response to malaria in children.
  • Offers potential biomarkers for predicting malaria outcomes in pediatric populations.
  • Informs strategies for managing pediatric malaria based on immune status and age.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...